Northrop Grumman

Analysts Boost Northrop Grumman Price Target Amid Defense Growth and Mixed Sector Outlook

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

18 Jul 24

Updated

03 Dec 25

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

18.7%

7D

3.8%

Loading

1Y

18.7%

7D

3.8%

You can edit this narrative until Dec 4 7:10 PM. Then, changes will post as Updates.

Author's Valuation

US$667.2114.6% undervalued

AnalystConsensusTarget Fair Value

Shared on 03 Dec 25

NOC: Future Defense Budgets Will Support Cash Flows And Share Outperformance

Analysts have modestly raised their price target on Northrop Grumman to approximately $670 per share, reflecting confidence in the company’s stable mid single digit growth outlook, expanding 2026 budget visibility across key programs, and improving long term cash generation from platforms like B 21 and Sentinel. Analyst Commentary Recent Street research reflects a generally constructive stance on Northrop Grumman, with multiple price target increases clustered around the mid to high $600s and at least one upgrade to a Buy rating.

Shared on 19 Nov 25

Fair value Increased 0.36%

NOC: Defense Spending Increases Will Drive Outperformance Amid Lower Execution Risks

Northrop Grumman’s analyst price target has been raised by analysts from approximately $665 to $667 per share. This reflects stable outlooks and optimism over growth in key defense programs and future cash generation.

Shared on 05 Nov 25

Fair value Increased 2.72%

NOC: Multi-Year Budget Allocations Will Likely Drive Strong Defense Sector Upside

Northrop Grumman's analyst price target was recently raised by analysts from approximately $647 to $665 per share. The increase reflects confidence in the company's stable growth outlook, strong alignment with strategic defense priorities, and anticipated benefits from new budget allocations and program execution.

Shared on 22 Oct 25

Fair value Increased 5.14%

Northrop Grumman's analyst price target was raised from approximately $616 to $647. Analysts cited increased confidence in the company's long-term defense program exposure and strong positioning within key Department of Defense budget priorities.

Shared on 08 Oct 25

Fair value Increased 2.03%

Northrop Grumman’s analyst price target has been raised from $603.32 to $615.56, reflecting analysts’ increased confidence in the company’s improving revenue growth, expanding profit margins, and favorable positioning within defense sector budgets. Analyst Commentary Recent analyst research has showcased a largely optimistic outlook on Northrop Grumman, with multiple firms raising their price targets and affirming positive ratings.

Shared on 06 Sep 25

Fair value Increased 0.88%

Analysts have raised Northrop Grumman’s price target to $603.32, citing accelerating revenue growth tied to Department of Defense priorities, robust international sales momentum, and strong Q2 performance, while valuation concerns and uncertainty around future earnings temper some optimism. Analyst Commentary Bullish analysts highlight accelerating revenue growth projected for the second half of 2025, underpinned by alignment with Department of Defense budget priorities and management’s positive outlook.

Shared on 07 May 25

Fair value Increased 11%

Shared on 30 Apr 25

Fair value Decreased 3.33%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 23 Apr 25

Fair value Increased 1.06%

AnalystConsensusTarget has increased revenue growth from 4.3% to 5.2%.

Shared on 16 Apr 25

Fair value Increased 2.73%

AnalystConsensusTarget has decreased shares outstanding growth rate from -0.0% to -0.0%.

Shared on 09 Apr 25

Fair value Decreased 0.55%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Decreased 0.46%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Decreased 0.48%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 10 Mar 25

Fair value Decreased 0.80%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget Fair Value

US$667.21

14.6% undervalued

Future estimation in

% p.a.

0

Decrease

Increase

Current revenue growth rate

5.17%

Aerospace & Defense revenue growth rate

0.53%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

7.99%

Calculation

US$4.51b

Earnings '28

x

25.51x

PE Ratio '28

=

US$114.93b

Market Cap '28

US$114.93b

Market Cap '28

/

136.78m

No. shares '28

=

US$840.24

Share Price '28

US$840.24 Share Price '28

Discounted to 2025 @ 8.20% p.a.

=

US$663.39

Fair Value '25